Angiotensin-converting enzyme inhibitors (ACEIs) are reported to reduce the incidence of aspiration pneumonia in hypertensive patients. In this study, a metaanalysis was conducted to obtain statistically more reliable estimates of outcome.
The MEDLINE and JMEDICINE databases were searched and the following study selection criteria were applied: (1) comparative controlled studies identified with the following keywords: drug therapy, ACEI, hypertension, swallowing function, dysphagia, stroke, and pneumonia; (2) a minimum follow-up period of 6 months; and (3) a minimum number of patients of more than 100. Patients with hypertension and a history of stroke or transient ischemic attack (TIA) in five controlled studies that reported the incidence of pneumonia were included in the analysis.
A total of 8,693 post-stroke patients were given ACEIs with another antihypertensive agent or placebo as a control. In all studies, ACEIs, particularly imidapril, exhibited preventive effects equating to a relative risk that ranged from 0.32 to 0.81 compared with controls. In the combined studies the overall relative risk of ACEI-treated patients versus controls was 0.61 (95% confidence intervals [CI] 0.51–0.75; P < 0.001). Among Asian patients, the relative risk was 0.42 (95% CI 0.32–0.56; P < 0.001). Among Japanese patients, an even greater preventive effect was found for ACEIs versus other antihypertensives (relative risk: 0.38 [95% CI 0.27-0.54; P < 0.001]).
ACEIs appear to be more effective than other antihypertensive agents or placebo in reducing pneumonia risk in post-stroke patients, especially in Asian populations.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344:665–671.
Pellegrini CA, DeMeester TR, Johnson LF, Skinner DB. Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality and results of surgical therapy. Surgery. 1979;86:110–119.
Loeb MB, Becker M, Eady A, Walker-Dilks C. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J Am Geriatr Soc. 2003;51:1018–1022.
Doggett DL, Tappe KA, Mitchell MD, Chapell R, Coates V, Turkelson CM. Prevention of pneumonia in elderly stroke patients by systematic diagnosis and treatment of dysphagia: an evidence-based comprehensive analysis of the literature. Dysphagia. 2001;16:279–295.
Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620–625.
Kimura K, Minematsu K, Kazui S, Yamaguchi T; the Japan Multicenter Stroke Investigators’ Collaboration (J-MUSIC). Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc Dis. 2005;19:171–178.
Nakagawa T, Wada H, Sekizawa K, Arai H, Sasaki H. Amantadine and pneumonia. Lancet. 1999;353:1157.
Yamaya M, Yanai M, Ohrui T, Arai H, Sekizawa K, Sasaki H. Antithrombotic therapy for prevention of pneumonia. J Am Geriatr Soc. 2001;49:687–688.
Shinohara Y; the CSPS Group. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. Cerebrovasc Dis. 2006;22:57–60.
Arai T, Yoshimi N, Fujiwara H, Fujiwara H, Sekizawa K. Serum substance P concentrations and silent aspiration in elderly patients with stroke. Neurology. 2003;61:1625–1626.
Sekizawa K, Matsui T, Nakagawa T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet. 1998;352:1069.
Ohkubo T, Chapman N, Neal B, et al; the Perindopril Protection Against Recurrent Stroke Study Collaborative Group. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med. 2004;169:1041–1045.
Arai T, Yasuda Y, Toshima S, Yoshimi N, Kashiki Y. ACE inhibitors and pneumonia in elderly people. Lancet. 1998;352:1937–1938.
Teramoto S. Novel preventive and therapeutic strategy for post-stroke pneumonia. Expert Rev Neurother. 2009;9:1187–1200.
Arai T, Yasuda Y, Takaya T, et al. ACE inhibitors and reduction of the risk of pneumonia in elderly people. Am J Hypertens. 2000;13:1050–1051.
Arai T, Yasuda Y, Takaya T, et al. Angiotensinconverting enzyme inhibitor, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke. Chest. 2001;119:660–661.
Akutagawa O, Honda K, Sasaki T. A study of prevention of pneumonia development in the elderly by ACE inhibitors. Progr Med. 2002;22:2705–2708. In Japanese.
Arai T, Sekizawa K, Ohrui T, et al. ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology. 2005;64:573–574.
Bender R. Calculating confidence intervals for the number needed to treat. Control Clin Trials. 2001;22:102–110.
Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications after acute stroke. Stroke. 1996;27:415–420.
Scottish Intercollegiate Guidelines Network. Management of patients with stroke: Identification and management of dysphagia. A national clinical guideline. Edinburgh: Elliott House; 2010.
MacMahon S, Collins R. Reliable assessment of the effects of treatment on mortality and major morbidity, II: Observational studies. Lancet. 2001;357:455–462.
Van de Garde EMW, Souverein PC, Hak E, Deneer VH, van den Bosch JM, Leufkens HG. Angiotensinconverting enzyme inhibitor use and protection against pneumonia in patients with diabetes. J Hypertens. 2007;25:235–239.
Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: A review of the literature and pathophysiology. Ann Intern Med. 1992;117:234–242.
Nakayama K, Sekizawa K, Sasaki H. ACE inhibitor and swallowing reflex. Chest. 1998;113:1425.
Itoh M, Meguro K, Fujiwara T, et al. Assessment of dopamine metabolism in brain of patients with dementia by means of 18F-fluorodopa and PET. Ann Nucl Med. 1994;8:245–251.
Yamaya M, Yanai M, Ohrui T, Arai H, Sasaki H. Interventions to prevent pneumonia among older adults. J Am Geriatr Soc. 2001;49:85–90.
Nakagawa T, Ohrui T, Sekizawa K, Sasaki H. Sputum substance P in aspiration pneumonia. Lancet. 1995;345:1447.
Cascieri MA, Bull HG, Mumford RA, Patchett AA, Thornberry NA, Liang T. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422. Mol Pharmacol. 1984;25:287–293.
Shore SA, Stimler-Gerard NP, Coats SR, Drazen JM. Substance P-induced bronchoconstriction in the guinea pig. Enhancement by inhibitors of neutral metalloendopeptidase and angiotensin-converting enzyme. Am Rev Respir Dis. 1988;137:331–336.
Sekizawa K, Jia YX, Ebihara T, Hirose Y, Hirayama Y, Sasaki H. Role of substance P in cough. Pulm Pharmacol. 1996;9:323–328.
Medhora M, Gao F, Jacobs ER, Moulder JE. Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology. 2012;17:66–71.
Woo J, Chan TYK. A high incidence of cough associated with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects. Br J Clin Pract. 1991;45:178–180.
Chan WK, Chan TYK, Luk WK, Leung VK, Li TH, Critchley JA. A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol. 1993;44:299–300.
Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol. 1995;40:141–144.
Sharpe N; the international HOPE TIPS investigators. The HOPE TIPS: the HOPE study translated into practices. Cardiovasc Drugs Ther. 2005;19:197–201.
Morimoto S, Okaishi K, Onishi M, et al. Deletion allele of the angiotensin-converting enzyme gene as a risk factor for pneumonia in elderly patients. Am J Med. 2002;112:89–94.
Saruta T, Omae T, Kuramochi M, et al. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control. J Hypertens. 1995;13(Suppl. 3):S23–S30.
Ebihara T, Sekizawa K, Nakazawa H, Sasaki H. Capsaicin and swallowing reflex. Lancet. 1993;341:432.
To view enhanced content go to www.advancesintherapy.com
About this article
Cite this article
Shinohara, Y., Origasa, H. Post-Stroke Pneumonia Prevention by Angiotensin-Converting Enzyme Inhibitors: Results of a Meta-analysis of Five Studies in Asians. Adv Therapy 29, 900–912 (2012). https://doi.org/10.1007/s12325-012-0049-1
- Angiotensin-converting enzyme inhibitor
- Aspiration pneumonia